Related Experiment Video
Updated: Apr 23, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Novel generations of influenza vaccines
George Kemble1, Harry Greenberg
1MedImmune Vaccines, 297 North Bernardo Avenue, Mountain View, CA 94043, USA. kembleg@medimmune.com
Abstract:
Several strategies are being pursued to increase the quality and quantity of influenza vaccines that are used on an annual basis including increasing the immunogenicity of currently licensed inactivated vaccines, delivery of inactive vaccines directly to the nasal mucosa, the use of cell lines for virus production and the use of live, attenuated vaccines. In addition, modern molecular biological techniques are being used to create and evaluate new vaccine approaches. This report will briefly review these different strategies and outline some of the potential advantages and challenges associated with them.
Related Concept Videos
Viral Recombination
Vaccinations
Leaky Scanning
Vaccine Production
Vaccines
Influenza

